We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
-19.38%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$398M
AUM Growth
-$344M
Cap. Flow
-$248M
Cap. Flow %
-62.23%
Top 10 Hldgs %
44.07%
Holding
188
New
36
Increased
27
Reduced
23
Closed
84

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$14.6M
2
CELG
Celgene Corp
CELG
+$10.8M
3
TLND
Talend S.A. American Depositary Shares
TLND
+$9.74M
4
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$9.08M
5
ZEN
ZENDESK INC
ZEN
+$8.55M

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$27M
2
KNX icon
Knight Transportation
KNX
+$17.2M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$15.8M
4
MGY icon
Magnolia Oil & Gas
MGY
+$14.6M
5
ADMS
Adamas Pharmaceuticals
ADMS
+$10.2M

Sector Composition

Rank Sector Weight
1 Technology 30.17%
2 Healthcare 20.63%
3 Industrials 11.87%
4 Utilities 10.14%
5 Consumer Staples 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JE
26
DELISTED
Just Energy Group Inc
JE
$5.91M 1.48%
54,242
+25,606
+89% +$2.98M
PVTL
27
DELISTED
Pivotal Software, Inc.
PVTL
$5.8M 1.46%
+354,900
New +$6.35M
OKTA icon
28
Okta
OKTA
$23.7B
$5.42M 1.36%
+85,000
New +$5.04M
VLO icon
29
Valero Energy
VLO
$88.7B
$4.87M 1.22%
+65,000
New +$5.71M
AMRS
30
DELISTED
Amyris Inc.
AMRS
$4.64M 1.17%
1,389,500
-960,367
-41% -$5.53M
IMMU
31
DELISTED
Immunomedics Inc
IMMU
$4.07M 1.02%
285,000
+12,500
+5% +$248K
CELG
32
CALL
DELISTED
Celgene Corp
CELG
$3.21M 0.81%
+50,000
New +$3.69M
SKY icon
33
Champion Homes
SKY
$4.58B
$3.16M 0.79%
215,000
+15,000
+8% +$331K
AIOT
34
PowerFleet Inc
AIOT
$525M
$2.73M 0.69%
489,088
+50,000
+11% +$301K
PGNX
35
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2.21M 0.56%
527,100
-1,517,900
-74% -$7.73M
GLNG icon
36
Golar LNG
GLNG
$4.95B
$2.18M 0.55%
100,000
-245,000
-71% -$6.33M
TTOO
37
DELISTED
T2 Biosystems, Inc
TTOO
$2.13M 0.54%
142
-45
-24% -$1.06M
PGNX
38
CALL
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$2.1M 0.53%
500,000
– –
FOLD
39
DELISTED
Amicus Therapeutics
FOLD
$2.06M 0.52%
215,000
-295,000
-58% -$3.24M
GS icon
40
Goldman Sachs
GS
$305B
$1.67M 0.42%
10,000
+7,500
+300% +$1.51M
DB icon
41
CALL
Deutsche Bank
DB
$67.6B
$1.63M 0.41%
200,000
+50,000
+33% +$488K
URI icon
42
United Rentals
URI
$67.9B
$1.54M 0.39%
+15,000
New +$1.81M
UNH icon
43
UnitedHealth
UNH
$389B
$1.5M 0.38%
6,000
– –
GWRS icon
44
Global Water Resources
GWRS
$215M
$1.19M 0.3%
117,000
-33,000
-22% -$345K
IBB icon
45
iShares Biotechnology ETF
IBB
$9.55B
$1.16M 0.29%
12,000
-500
-4% -$53.1K
CI icon
46
Cigna
CI
$79.6B
$1.14M 0.29%
6,000
– –
AMZN icon
47
Amazon
AMZN
$2.48T
$1.05M 0.26%
+14,000
New +$1.16M
AMD icon
48
Advanced Micro Devices
AMD
$741B
$1.01M 0.25%
+55,000
New +$1.19M
ULTI
49
DELISTED
Ultimate Software Group Inc
ULTI
$979K 0.25%
4,000
+3,000
+300% +$795K
DAR icon
50
Darling Ingredients
DAR
$9.28B
$962K 0.24%
+50,000
New +$1.01M
1
2
3 4 5

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return

Ardsley Advisory Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Ardsley Advisory Partners held 188 positions worth $398M, down 46% from $742M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Ardsley Advisory Partners withdrew a net $248M in Q4 2018, closing 84 positions and reducing 23 holdings. Its most notable exit was Marathon Petroleum, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ardsley Advisory Partners opened a new position in CVS Health worth $12.8M.

  • Ardsley Advisory Partners's largest Q4 2018 buy was CVS Health: 195,000 shares worth $12.8M.
  • Ardsley Advisory Partners added most to Celgene Corp in Q4 2018, an estimated $10.8M increase.
  • Ardsley Advisory Partners's biggest Q4 2018 reduction was Progenics Pharmaceuticals Inc, cutting an estimated $7.73M.
  • Ardsley Advisory Partners fully exited Marathon Petroleum in Q4 2018, selling an estimated $27M.
  • Ardsley Advisory Partners's ten largest holdings make up 44% of its $398M portfolio in Q4 2018.
  • Ardsley Advisory Partners opened 36 new positions and closed 84 in Q4 2018.
  • Ardsley Advisory Partners's portfolio value fell 46% quarter-over-quarter to $398M.

Based on Ardsley Advisory Partners's 13F filing for Q4 2018, filed 14 Feb 2019.